Winning proposal to create a corporate social responsibility (CSR) programme.
April 5, 2017
Insight into human behaviour allows development of programmes that help doctors diagnose rare diseases.
Sandoz’s CEO Richard Francis on the latest developments in biosimilars.
NHS England’s chief executive, Simon Stevens, recently stated that focus must be put on care in the community and in the home to tackle the huge deficits facing NHS trusts.
Four international trials will speed development of technology
What changes will STPs bring and what are the implications for pharma?
Proactive and included patients can help clinical trial retention.